Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Current Assets (2016 - 2026)

Dexcom has reported Current Assets over the past 17 years, most recently at $4.3 billion for Q1 2026.

  • Quarterly Current Assets fell 4.88% to $4.3 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $4.3 billion through Mar 2026, down 4.88% year-over-year, with the annual reading at $4.0 billion for FY2025, 6.23% down from the prior year.
  • Current Assets was $4.3 billion for Q1 2026 at Dexcom, up from $4.0 billion in the prior quarter.
  • Over five years, Current Assets peaked at $5.2 billion in Q3 2025 and troughed at $3.4 billion in Q3 2022.
  • The 5-year median for Current Assets is $4.3 billion (2026), against an average of $4.3 billion.
  • Year-over-year, Current Assets soared 38.25% in 2023 and then dropped 9.27% in 2024.
  • A 5-year view of Current Assets shows it stood at $3.7 billion in 2022, then grew by 20.64% to $4.4 billion in 2023, then decreased by 2.81% to $4.3 billion in 2024, then decreased by 6.23% to $4.0 billion in 2025, then grew by 7.4% to $4.3 billion in 2026.
  • Per Business Quant, the three most recent readings for DXCM's Current Assets are $4.3 billion (Q1 2026), $4.0 billion (Q4 2025), and $5.2 billion (Q3 2025).